Description

OraQuick® HCV Rapid Antibody Test

The first and only FDA-approved, point-of-care test for hepatitis C (HCV) antibodies that meets the new guidelines. This has been licensed by Health Canada in January 2017 for commercial sale in Canada.

Advantages of OraQuick® HCV 

• Accurate: Reliable results with >98% accuracy.
• Simple: 3-easy steps; CLIA-waived
• Fast: Test and result delivery in 20 minutes for immediate linkage to care.
• Recommended: Both the CDC and AASLD have issued new screening guidelines in an effort to identify these HCV positive people before it’s too late.
• Flexible: Specimens for Clinical and Non-Clinical Settings

OraQuick® is appropriate for testing in locations such as:

• Public Health Settings
• Physician Offices
• Community-Health Clinics
• Laboratories
• Emergency Rooms